Compare AVTX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | INTT |
|---|---|---|
| Founded | 2011 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 982.5M | 139.2M |
| IPO Year | 2015 | 1997 |
| Metric | AVTX | INTT |
|---|---|---|
| Price | $16.08 | $10.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $40.57 | $13.50 |
| AVG Volume (30 Days) | ★ 870.6K | 100.7K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $27,813,137.00 | ★ $66,801,000.00 |
| Revenue This Year | N/A | $15.82 |
| Revenue Next Year | N/A | $9.10 |
| P/E Ratio | ★ N/A | $177.83 |
| Revenue Growth | ★ 2312.27 | 66.06 |
| 52 Week Low | $9.54 | $7.07 |
| 52 Week High | $24.27 | $20.00 |
| Indicator | AVTX | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 32.92 | 36.90 |
| Support Level | $15.24 | $10.32 |
| Resistance Level | $16.80 | $10.88 |
| Average True Range (ATR) | 1.04 | 0.49 |
| MACD | -0.45 | 0.06 |
| Stochastic Oscillator | 12.25 | 22.88 |
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.